Epigenetic Clock vs Glycan Clock Compared

Epigenetic Clocks vs Glycan Clocks: Which Biological Age Test Should You Choose?

Professional headshot of The GlycanAge Team
Author: The GlycanAge Team
Calendar icon
Published: November 20, 2026

Epigenetic clocks track long-term aging risk; glycan clocks like GlycanAge reveal if your interventions work in months. Compare and choose.

Epigenetic Clocks vs Glycan Clocks: Which Biological Age Test Should You Choose?

If you're already tracking biomarkers as part of a longevity routine, you've probably run into two very different aging clocks: the epigenetic clock and the glycan clock. Both estimate biological age, but they're built to answer different questions, and picking the wrong one for your goal means you won't get the answer you're actually looking for.

This isn't really a question of which clock is better. It's a question of matching the tool to the job, whether that's finding out if a new intervention is working right now, or projecting long-term health span risk.

New to biological age testing? Read the complete guide to measuring how fast you're actually aging before diving into how these two clocks compare.


What the epigenetic clock measures

Epigenetic aging refers to changes in the chemical tags (methyl groups) that attach to DNA over time, altering gene expression and, over the long run, contributing to age-related disease risk. Methylation patterns shift as we age, and researchers have identified specific genome sites where those shifts happen predictably enough to estimate biological age.

The best-known example is the Horvath clock, developed by Steve Horvath at UCLA, which is based on methylation patterns at 353 CpG sites across the genome. It's highly accurate at estimating chronological age, which is also its main limitation: when a clock tracks chronological age too closely, it leaves less room to capture meaningful biological deviation. That's part of why "second generation" clocks like PhenoAge and GrimAge were developed, calibrated against known health outcomes rather than age alone.

A newer entrant, TruDiagnostic, uses a blood sample and a large panel of methylation sites to generate its biological age and pace-of-aging scores. Tally Health has taken a different route with its buccal-swab test, built on its proprietary CheekAge clock, trained on methylation data from over 8,000 adults. A cheek swab is more practical to collect than a blood draw, but it also means the reading is limited to methylation changes in epithelial cells from the mouth rather than blood.

Across epigenetic clocks generally, the strongest evidence base sits around long-term mortality and disease risk prediction, and around forensic applications like age estimation. It's worth noting that "epigenetic clock" is a generic term for a family of different clocks, and findings from one don't automatically transfer to another.


What the glycan clock measures

Glycosylation is the enzymatic attachment of complex carbohydrates, glycans, to proteins, lipids, RNA and cellular membranes. On immunoglobulin G (IgG), the most common antibody in the blood, this process directly shapes how inflammatory or anti-inflammatory that antibody behaves. IgG tends to become more pro-inflammatory with age, and that shift is linked to cardiovascular disease, renal decline, autoimmunity and cognitive decline.

Because glycans sit on a functional immune molecule rather than on DNA, the glycan clock isn't just recording that aging happened. It's measuring an active driver of the inflammatory processes behind it, which is also why it responds to change differently than a methylation-based clock does.

"Glycans were not particularly helpful in predicting chronological age. They performed medium amongst the spectrum of eleven clocks we studied. But what we did see, perhaps not surprisingly but very optimistically, was that glycan age was predictive of health outcomes, not surprising perhaps because it has to do with your immune system."

— Dr Peter Joshi, Chief Scientist, Humanity Health; University of Edinburgh


GlycanAge: the glycan aging clock

GlycanAge is the first and only aging clock built on glycans, developed by our founder, Professor Gordan Lauc, at the Genos Glycoscience Laboratory, the world's largest lab for high-throughput glycan analysis.

A study of more than 5,000 individuals, published in 2014, found that IgG glycans change with age in a way that can also be biologically informative when the estimate deviates from chronological age. That deviation tracks with disease-risk markers including high blood pressure, insulin, glucose, cholesterol, LDL, BMI and HbA1c, and people with a higher biological than chronological age tend to see faster health decline overall. Separate longitudinal research has found glycan changes emerging 6 to 10 years before diagnosis of conditions like insulin resistance and type 2 diabetes, with cardiovascular-specific changes visible up to 8 years ahead of a clinical event.

One of the clock's standout strengths is that it reveals elevated hospitalization risk across an unusually broad set of conditions, including influenza and pneumonia, circulatory disease, diabetes and other metabolic disease, because glycans function as both a marker of that risk and a mechanism behind it.

The test itself uses a finger-prick sample, just 4 dry drops of blood, to generate a readout of 29 glycan structures. That result is compared against glycan profiles from 250,000+ people aged 20 to 80 to calculate biological age, with results delivered on a client dashboard alongside complimentary guidance from a longevity specialist.


Why responsiveness is the real differentiator

This is where the two clocks diverge most in practice. Epigenetic clocks, particularly first-generation ones, tend to shift slowly and are built and validated primarily against long-term mortality and disease outcomes. They're strong at projecting where someone is headed over years or decades.

Glycans, by contrast, are functional effectors sitting on an active immune molecule, which makes the glycan clock inherently more reactive to what's happening now: a new training block, a supplement protocol, a change in sleep, hormone therapy. GlycanAge recommends retesting 3 to 4 months after starting a pharmaceutical or hormone-based intervention, and 6 to 12 months after a lifestyle change, which is enough time for the biological signal to stabilize into a result worth acting on.

"With glycans, you do a lifestyle intervention and then after a couple of months you check whether it works or not. That's very different from genes, which don't change at all, or from metabolites and enzymes, which change too quickly to be useful. Glycans sit in between, and that's what makes them such an important prognostic biomarker."

— Prof. Gordan Lauc, Professor of Biochemistry and Molecular Biology, University of Zagreb, and Co-Founder & Chief Scientific Officer, GlycanAge

That gap in responsiveness, not accuracy, is the main reason these two clocks tend to get used for different jobs.


Matching the test to the goal

Goal

Better fit

Why

Checking whether a new supplement, training block or hormone protocol is working

Glycan clock

Reflects change within the 3 to 4 month (pharmaceutical/HRT) or 6 to 12 month (lifestyle) retest window

Building a long-term health span or mortality risk baseline

Epigenetic clock

Validated primarily against long-run mortality and disease outcome data

Risk stratification in a functional medicine setting

Both together

Glycan clock flags current inflammatory burden; epigenetic clock adds longer-horizon context

Rapid iteration on lifestyle or biohacking experiments

Glycan clock

Sensitive enough to show movement between short retest cycles

Used together, the two clocks aren't redundant. An epigenetic result sets the long-range baseline; a glycan result shows whether what's being done right now is actually moving the needle before waiting years to find out.

"GlycanAge actually shows a stronger association with type 2 diabetes than GrimAge, which given the nature of glycans, one might expect. It would be nice to see glycans, proteins and methylation measured in a large cohort of the same individuals so we can really look at whether there are additive contributions, and my guess is that there will be."

— Prof. Riccardo Marioni, Chair of Molecular Epidemiology of Aging, University of Edinburgh


Biological noise: what can throw off a reading

Neither clock exists in a vacuum, and both can be affected by factors that aren't really about aging at all. Because glycans respond to active immune activity, a recent infection, acute injury or a flare of an existing inflammatory condition can temporarily shift a glycan-based reading, which is why it's worth avoiding testing during an acute illness and retesting once things have settled. Epigenetic clocks are generally more stable over short timeframes, but they aren't immune to confounding either: factors like smoking history, certain medications and some acute health events have been associated with methylation shifts in the research literature.

The practical takeaway for either test: a single, moment-in-time result is a snapshot, not a verdict, and repeat testing over time is what turns either clock into a genuinely useful trend line.


Which one should you start with?

If the question is "is what I'm doing right now working," start with the glycan clock. It's built to move on the same timeline as an intervention.

If the question is "where is my long-term health trending," an epigenetic clock is designed to answer that.

If the honest answer is "both," that's not indecision, it's the more complete picture: a long-range baseline from an epigenetic clock, paired with a glycan clock to check whether the changes made along the way are actually shifting the immune and inflammatory processes that drive how fast someone ages.

Curious what your own glycan clock would show? Order a GlycanAge test kit and get a baseline reading to build the rest of your longevity stack around.


External sources

  • Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. Link: https://pubmed.ncbi.nlm.nih.gov/24138928/

  • Krištić J, Vučković F, Menni C, Klarić L, Keser T, Beceheli I, et al. Glycans are a novel biomarker of chronological and biological age. J Gerontol A Biol Sci Med Sci. 2014;69(7):779-789. Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7732334/

  • Shokhirev MN, Torosin NS, Kramer DJ, Johnson AA, Cuellar TL. CheekAge: a next-generation buccal epigenetic aging clock associated with lifestyle and health. Geroscience. 2024;46(3):3429-3443. Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11009193/

  • Cvetko A, Mangino M, Tijardović M, Kifer D, Falchi M, Keser T, et al. Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches. BMJ Open Diabetes Res Care. 2021;9(1):e002263. Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8438737/

  • Macdonald-Dunlop E, Taba N, Klarić L, Frkatović A, Walker R, Hayward C, et al. A catalogue of omics biological aging clocks reveals substantial commonality and associations with disease risk. Aging (Albany NY). 2022;14(2):623-659. Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8833109/

Professional head shot of The GlycanAge Team
Author: The GlycanAge Team
Calendar icon
Category: Health
2 glycanage testing kits

The Future of Healthcare is Preventative, Personalised, and Powered by Glycans

Whether you’re improving your own health, supporting patients, or driving research, GlycanAge helps you turn science into action.

Other articles you may like:
Blog image
Health Liya Grudeva

The Science of Resilience: How Our Bodies Maintain Balance Under Pressure

Resilience goes beyond our ability to cope with stress. It also involves how our bodies adapt to physical, psychological, and environmental challenges while maintaining healthy function. This article explores the immune system's role in resilience, how inflammatory regulation influences our response to life's demands, and why some people may be more resilient than others.

Calendar icon Published:
November 19, 2026
Reading time icon Reading time:
15 minutes
Read the full article
Blog image
Health The GlycanAge Team

Glycans and Brain Health: The Sugar-Cognition Connection Behind Neurodegeneration

Explore the intricate relationship between glycans and brain health, uncovering how sugar impacts cognition and contributes to neurodegeneration.

Calendar icon Published:
November 19, 2026
Reading time icon Reading time:
10 minutes
Read the full article